These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
252 related items for PubMed ID: 32708166
1. The Role of Methionine Aminopeptidase 2 in Lymphangiogenesis. Esa R, Steinberg E, Dror D, Schwob O, Khajavi M, Maoz M, Kinarty Y, Inbal A, Zick A, Benny O. Int J Mol Sci; 2020 Jul 21; 21(14):. PubMed ID: 32708166 [Abstract] [Full Text] [Related]
2. Effect of nitroxoline on angiogenesis and growth of human bladder cancer. Shim JS, Matsui Y, Bhat S, Nacev BA, Xu J, Bhang HE, Dhara S, Han KC, Chong CR, Pomper MG, So A, Liu JO. J Natl Cancer Inst; 2010 Dec 15; 102(24):1855-73. PubMed ID: 21088277 [Abstract] [Full Text] [Related]
3. Methionine aminopeptidase‑2 is a pivotal regulator of vasculogenic mimicry. Shimizu S, Kawahara R, Simizu S. Oncol Rep; 2022 Feb 15; 47(2):. PubMed ID: 34913067 [Abstract] [Full Text] [Related]
5. Selective inhibition of amino-terminal methionine processing by TNP-470 and ovalicin in endothelial cells. Turk BE, Griffith EC, Wolf S, Biemann K, Chang YH, Liu JO. Chem Biol; 1999 Nov 15; 6(11):823-33. PubMed ID: 10574784 [Abstract] [Full Text] [Related]
7. Kallistatin exerts anti-lymphangiogenic effects by inhibiting lymphatic endothelial cell proliferation, migration and tube formation. Ma C, Yin H, Zhong J, Zhang Y, Luo C, Che D, Fang Z, Li L, Qin S, Liang J, Qi W, Yang Z, Zhou T, Ma J, Yang X, Gao G. Int J Oncol; 2017 Jun 15; 50(6):2000-2010. PubMed ID: 28440474 [Abstract] [Full Text] [Related]
9. Pharmacological Characterization of SDX-7320/Evexomostat: A Novel Methionine Aminopeptidase Type 2 Inhibitor with Anti-tumor and Anti-metastatic Activity. Cornelius P, Mayes BA, Petersen JS, Turnquist DJ, Dufour PJ, Dannenberg AJ, Shanahan JM, Carver BJ. Mol Cancer Ther; 2024 May 02; 23(5):595-605. PubMed ID: 38530115 [Abstract] [Full Text] [Related]
10. Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion. Tacconi C, Correale C, Gandelli A, Spinelli A, Dejana E, D'Alessio S, Danese S. Gastroenterology; 2015 Jun 02; 148(7):1438-51.e8. PubMed ID: 25754161 [Abstract] [Full Text] [Related]
11. Using Target Engagement Biomarkers to Predict Clinical Efficacy of MetAP2 Inhibitors. Farrell PJ, Zopf CJ, Huang HJ, Balakrishna D, Holub C, Bilakovics J, Fanjul A, Matuszkiewicz J, Plonowski A, Rolzin P, Banerjee U, Ermolieff J, Cheruvallath ZS, McBride C, Bartkowski D, Mazur C, Pachori A, Larson CJ. J Pharmacol Exp Ther; 2019 Nov 02; 371(2):299-308. PubMed ID: 31537613 [Abstract] [Full Text] [Related]
15. Phomaketide A Inhibits Lymphangiogenesis in Human Lymphatic Endothelial Cells. Tai HC, Lee TH, Tang CH, Chen LP, Chen WC, Lee MS, Chen PC, Lin CY, Chi CW, Chen YJ, Lai CT, Chen SS, Liao KW, Lee CH, Wang SW. Mar Drugs; 2019 Apr 06; 17(4):. PubMed ID: 30959907 [Abstract] [Full Text] [Related]
18. Tumor necrosis factor superfamily 15 promotes lymphatic metastasis via upregulation of vascular endothelial growth factor-C in a mouse model of lung cancer. Qin T, Huang D, Liu Z, Zhang X, Jia Y, Xian CJ, Li K. Cancer Sci; 2018 Aug 06; 109(8):2469-2478. PubMed ID: 29890027 [Abstract] [Full Text] [Related]
19. Methionine aminopeptidase 2 is required for HSC initiation and proliferation. Ma AC, Fung TK, Lin RH, Chung MI, Yang D, Ekker SC, Leung AY. Blood; 2011 Nov 17; 118(20):5448-57. PubMed ID: 21937698 [Abstract] [Full Text] [Related]